Table 2.

Quality of Life measures and patient-based outcomes at baseline and 18 months.

	Intervention group	Control group
QoL (EQ-5D) score, mean (SD)
Baseline	0.819 (0.80–0.84)	0.789 (0.77–0.81)
18 months	0.904 (0.89–0.92)	0.843 (0.83–0.86)
Δ pre and post intervention	0.084	0.053
18 month crude QALYs, mean (95% CI)	1.295 (1.28–1.31)	1.229 (1.21–1.25)
Difference	0.067 (0.04–0.09)
18 month adjusted QALYs, mean (95% CI)
Difference adjusted for baseline utility	0.040 (0.006–0.074)
Difference adjusted for baseline utility and other variables*	0.042 (0.007–0.077)
18 month SBP net difference from baseline, mmHg (95% CI)
Crude difference	−6.316 (−12.18, −0.45)
Adjusted difference*	−5.302 (−10.34, −0.265)

Notes:

^*Adjusted for sex, age, SBP, history CVD and history of hypercholesterolemia at baseline.

QoL: Quality of Life; QALYs: Quality-Adjusted Life Years; EQ-5D: EuroQol 5D; SBP: Systolic Blood Pressure